Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.7K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.7K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

8.1K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
8.1K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

85
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

410
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
410

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2025
Same author

Optimal designs for efficacy-toxicity response in dose finding studies using the bivariate probit model.

Computers in biology and medicine·2025
Same author

Optimum designs for clinical trials in personalized medicine when response variance depends on treatment.

Journal of biopharmaceutical statistics·2024
Same author

Modeling the Batch Sedimentation of Calcium Carbonate Particles in Laboratory Experiments-A Systematic Approach.

Materials (Basel, Switzerland)·2023
Same author

Randomizing a clinical trial in neuro-degenerative disease.

Contemporary clinical trials communications·2023
Same author

On the Design of Aqueous Emulsions of Colophony Resin.

Polymers·2023
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Sep 9, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.6K

Model robust designs for dose-response models.

Belmiro P M Duarte1,2,3, Anthony C Atkinson4, Nuno M C Oliveira3

  • 1Departamento de Engenharia Química e Biológica, Instituto Superior de Engenharia de Coimbra, Rua Pedro Nunes, Quinta da Nora, 3030-199 Coimbra, Portugal.

Biometrics
|August 28, 2025
PubMed
Summary
This summary is machine-generated.

Designing experiments when the true model is unknown requires a model robust design approach. This study presents Semidefinite Programming formulations for optimal robust experimental designs, improving data collection efficiency.

Keywords:
D-optimality criterionLäuter’s robustness criteriaSemidefinite Programmingdose-response modelsmodel robust designs

More Related Videos

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.7K

Related Experiment Videos

Last Updated: Sep 9, 2025

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.6K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.9K
Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

6.7K

Area of Science:

  • Statistics
  • Experimental Design
  • Mathematical Modeling

Background:

  • Optimal experimental design typically assumes a known model structure.
  • Model uncertainty, common in fields like dose-response modeling, can lead to inefficient experimental plans if based on a single assumed model.
  • Model robust design aims to mitigate the impact of this uncertainty.

Purpose of the Study:

  • To systematically develop approximate optimal model robust experimental designs.
  • To address the challenge of selecting experimental designs when the underlying model is uncertain.
  • To provide a framework for designing experiments robust to a pool of potential models.

Main Methods:

  • Developed three Semidefinite Programming (SDP)-based formulations for model robust designs.
  • Leveraged the semidefinite representability of robustness criteria for problem formulation.
  • Employed standardized designs to ensure comparability of information measures across different models.
  • Focused on locally optimal designs, accommodating nonlinear models within the candidate pool.

Main Results:

  • Presented novel SDP formulations for approximate optimal model robust experimental designs.
  • Demonstrated the applicability of the approach using a dose-response study with seven candidate models.
  • Showcased how standardized designs facilitate cross-model information measure comparison.

Conclusions:

  • The proposed SDP-based approach offers a systematic method for constructing model robust experimental designs.
  • This methodology enhances the efficiency and adequacy of data collection when model uncertainty exists.
  • The framework is particularly useful in applications like dose-response studies with multiple potential models.